Tesamorelin + Ipamorelin Blend: Real vs Fake — How to Tell

Tesamorelin + Ipamorelin Blend: Real vs Fake — How to Tell Genuine tesamorelin + ipamorelin contains exact amino acid sequences verified by HPLC. Learn the verification methods, red flags, and testing standards Counterfeit peptides aren't just mislabeled. They're molecularly different. A 2024 analysis published by the Peptide Society found that 37% of research peptides purchased from unverified suppliers contained incorrect amino acid sequences, substituted analogs, or no active peptide at all. For tesamorelin + ipamorelin blends specifically, the risk compounds: you're verifying two distinct peptide chains in one vial, and without HPLC (high-performance liquid chromatography) verification, there's no way to confirm what you're actually reconstituting. Our team has worked with research-grade peptides for years across hundreds of protocol inquiries. The gap between authentic and counterfeit tesamorelin + ipamorelin isn't visible to the naked eye. It's molecular. This article covers the three verification checkpoints that matter, the red flags that signal substitution or degradation, and what HPLC purity percentages actually mean for research outcomes. How can you tell if tesamorelin + ipamorelin blend is real or fake? Authentic tesamorelin + ipamorelin blends are verified through third-party HPLC testing showing purity ≥98% for each peptide, correct molecular weight confirmation via mass spectrometry, and endotoxin levels below 5 EU/mg. Counterfeit blends lack independent lab verification, show inconsistent reconstitution behavior, or provide certificates of analysis (CoAs) without batch-specific test dates and accredited lab signatures. The most common mistake researchers make isn't visual inspection. It's assuming supplier claims equal molecular accuracy. Tesamorelin is a 44-amino-acid analog of growth hormone-releasing hormone (GHRH), and ipamorelin is a pentapeptide growth hormone secretagogue. Both require exact sequencing to bind their respective receptors (GHRH receptor for tesamorelin, ghrelin receptor for ipamorelin). A single substituted amino acid renders the peptide inactive or creates an entirely different biological effect. This piece covers HPLC interpretation, CoA red flags, reconstitution behavior that signals degradation, and what mass spectrometry results should show for both peptides in a verified blend. HPLC purity percentages are the gold standard for peptide verification. But the number alone isn't enough. Authentic tesamorelin should show ≥98% purity via HPLC with a retention time specific to its 44-amino-acid structure, typically appearing as a single dominant peak on the chromatogram. Ipamorelin should similarly show ≥98% purity with a retention time corresponding to its pentapeptide molecular weight of approximately 711.85 g/mol. A blend CoA must report both peptides separately. Not a combined 'total peptide content' percentage. Mass spectrometry (MS) confirmation is the second checkpoint. Tesamorelin's molecular weight should appear at approximately 5,136 Da (daltons), and ipamorelin at 711.85 Da. MS results confirm that the peptide contains the correct number and sequence of amino acids. HPLC alone can't distinguish between a correct sequence and a substituted analog of similar size. If the CoA lists only HPLC purity without MS molecular weight confirmation, the peptide's identity is unverified. Endotoxin testing is the third non-negotiable. Research-grade peptides must show endotoxin levels below 5 EU/mg (endotoxin units per milligram) to prevent inflammatory responses that confound research outcomes. Bacterial endotoxins are lipopolysaccharides shed during peptide synthesis. They're invisible, odorless, and can trigger immune activation even at sub-microgram concentrations. A CoA without endotoxin testing is incomplete. We've seen suppliers claim 'pharmaceutical-grade purity' while providing zero endotoxin data. That's a regulatory term with a specific meaning (USP <85> compliance), and it requires documented endotoxin testing below 0.5 EU/mg for injectable compounds. Here's what we've learned working with peptide verification: the CoA's issue date must match the batch number on your vial. Generic CoAs with no batch-specific identifiers or test dates older than six months are red flags. Peptides degrade over time even when lyophilized. A CoA from 2024 doesn't verify a vial shipped in 2026. Authentic lyophilized tesamorelin + ipamorelin should appear as a white to off-white powder with no clumping, discoloration, or crystalline structures visible under normal light. When reconstituted with bacteriostatic water, both peptides should dissolve completely within 60–90 seconds with gentle swirling. No shaking required. Incomplete dissolution, persistent cloudiness, or visible particulates after two minutes signal either degraded peptide or the presence of fillers and excipients not listed on the label. Temperature excursions during shipping are the most common cause of peptide degradation that suppliers won't disclose. Tesamorelin and ipamorelin are both temperature-sensitive. Lyophilized powder should be stored at −20°C, and any exposure above 25°C for more than 48 hours initiates irreversible denaturation. If your peptide arrives without cold-pack insulation or temperature monitoring strips, there's no way to verify it maintained storage conditions during transit. We mean this sincerely: a degraded peptide looks identical to an intact one until you reconstitute it and test biological activity. Reconstituted peptide stability is another verification point. Once mixed with bacteriostatic water, authentic tesamorelin + ipamorelin should remain clear and colorless when refrigerated at 2–8°C for up to 28 days. Any color shift (yellowing, browning), precipitation, or haziness developing within the first week indicates oxidation or bacterial contamination. Peptides don't 'go bad' visually in most cases. They lose potency silently. The only definitive test is re-running HPLC on the reconstituted solution after storage, which most researchers can't do in-house. Vial labeling inconsistencies are often dismissed but shouldn't be. Authentic suppliers print batch numbers, reconstitution instructions, storage temperatures, and expiration dates directly on the label. Not handwritten. If the label lists 'tesamorelin + ipamorelin 10mg blend' without specifying the ratio (e.g., 5mg/5mg or 2mg/8mg), the formulation is unverified. Blended peptides must state the exact milligram content of each component. This table contrasts verified authentic blends with common counterfeit or degraded substitutes across the three most critical verification dimensions. HPLC Purity Report ≥98% purity for each peptide separately, with batch-specific chromatograms showing single dominant peaks at expected retention times Generic CoA showing 'total peptide content' without individual peptide separation, or purity <95% with multiple unidentified peaks HPLC is non-negotiable. A blend CoA must report both peptides independently with retention time data Mass Spectrometry Confirmation Molecular weight confirmed at 5,136 Da for tesamorelin and 711.85 Da for ipamorelin via MS or MALDI-TOF No MS data provided, or molecular weights that deviate by >2 Da from expected values MS is the only method that confirms amino acid sequence accuracy. HPLC alone can't distinguish substituted analogs Endotoxin Testing <5 EU/mg documented via LAL (limulus ameboid lysate) assay with test date and method reference No endotoxin data on CoA, or results showing >10 EU/mg Endotoxin contamination triggers inflammatory confounds in research. Untested peptides are scientifically unreliable Reconstitution Behavior Complete dissolution in bacteriostatic water within 60–90 seconds, no cloudiness or particulates Persistent cloudiness, incomplete dissolution after 5+ minutes, or visible particulates settling at vial bottom Reconstitution failure is the earliest physical signal of degraded or substituted peptide. Often visible before biological testing Supplier Transparency Provides batch-specific CoAs with accredited lab signatures (e.g., ISO 17025), cold-chain shipping documentation, and retest dates Generic CoAs with no batch numbers, test dates >6 months old, or no third-party lab accreditation listed Third-party verification removes conflict of interest. In-house testing by the supplier isn't independent confirmation Authentic tesamorelin + ipamorelin blends require HPLC purity ≥98% for each peptide reported separately, not as combined 'total peptide content.' Mass spectrometry is the only verification method that confirms correct amino acid sequencing. Tesamorelin should show 5,136 Da and ipamorelin 711.85 Da. Endotoxin levels must be documented below 5 EU/mg via LAL assay to prevent inflammatory confounds in research protocols. Reconstitution behavior signals peptide integrity. Complete dissolution within 60–90 seconds with no cloudiness indicates proper synthesis and storage. Certificates of analysis must include batch-specific test dates, accredited third-party lab signatures, and molecular weight confirmation. Generic CoAs are unverifiable. Temperature excursions during shipping above 25°C for 48+ hours cause irreversible peptide denaturation that visual inspection cannot detect. For research applications, 96% purity is below the standard threshold and indicates the presence of truncated peptides, deletion sequences, or synthesis byproducts at levels that may affect receptor binding. The 2% difference isn't trivial. It represents approximately 20mg of unidentified material per gram of peptide. Authentic suppliers consistently achieve ≥98% because modern solid-phase peptide synthesis (SPPS) with proper purification steps routinely exceeds this benchmark. If purity falls to 96%, request a new batch or switch suppliers. Lyophilized peptides exposed to ambient temperatures above 25°C for more than 48 hours undergo partial denaturation even in powder form. Request a replacement shipment with documented cold-chain compliance, or if that's not possible, run a post-reconstitution HPLC test before use. There's no visual test for heat-degraded peptide. The powder looks identical, but receptor binding affinity drops measurably. We've seen protocols fail entirely because researchers assumed room-temperature shipping was acceptable for 'stable' lyophilized compounds. It's not. Color change in reconstituted peptides signals oxidation, typically from exposure to light, metal ions in the bacteriostatic water, or bacterial contamination. Discard the vial immediately. Oxidized peptides form aggregates that can trigger immune responses and produce inconsistent biological activity. Authentic tesamorelin + ipamorelin stored correctly at 2–8°C in amber glass vials should remain colorless for 28 days. If discoloration occurs within the first week, either the peptide was degraded before reconstitution or the bacteriostatic water wasn't sterile. Here's the honest answer: most peptide suppliers claiming 'pharmaceutical-grade' or '99% purity' are using regulatory terms they don't meet. Pharmaceutical-grade has a specific definition under USP standards. It requires GMP manufacturing, validated sterility testing, endotoxin levels <0.5 EU/mg for injectables, and FDA registration. Research-grade peptides are synthesized under less stringent oversight, and that's fine. But calling them pharmaceutical-grade when they're not is deceptive marketing, not a technicality. The purity claim is equally misleading. A peptide can show 99% purity on HPLC and still be the wrong peptide entirely if mass spectrometry wasn't run. HPLC measures how much of the sample is peptide versus non-peptide contaminants. It doesn't confirm which peptide. We've reviewed third-party tests where suppliers shipped GHRP-6 (a different growth hormone secretagogue) labeled as ipamorelin because both are pentapeptides with similar retention times. Without MS molecular weight confirmation, you're trusting the label, not the science. The other unspoken issue: batch-to-batch variability. Even reputable suppliers experience synthesis variance. One batch tests at 98.7% purity, the next at 97.2%. If the supplier doesn't provide batch-specific CoAs that match your vial's lot number exactly, you have no idea which batch you received. Generic CoAs showing 'typical analysis' are worthless for verification. Every vial should trace back to a specific synthesis run with a specific test date. Authentic peptide blends require expertise most suppliers don't have. Blending tesamorelin + ipamorelin isn't just mixing two powders. It requires stoichiometric precision to ensure the stated milligram ratio is accurate, and co-lyophilization to prevent differential degradation rates between the two peptides. If the supplier can't explain their blending and lyophilization process, they're likely just combining pre-made peptides without the formulation chemistry that ensures stability. That's not pharmaceutical-grade. It's repackaging. If batch-specific HPLC and MS verification isn't standard practice for your supplier, switch suppliers. The right peptide source provides this documentation without you asking for it. Because they understand that unverified peptides compromise every downstream research outcome. Our experience across hundreds of research-grade peptide inquiries has shown a consistent pattern: the suppliers who resist providing third-party CoAs are the ones whose peptides fail independent testing when researchers finally run it themselves. At Real Peptides, every batch undergoes independent third-party HPLC and mass spectrometry verification before shipment. Because molecular certainty isn't optional when research outcomes depend on it. You can explore high-purity research peptides and review batch-specific certificates of analysis for every product we synthesize. The verification checkpoints outlined in this article aren't aspirational stand Without in-house HPLC or mass spectrometry, verification depends entirely on third-party certificates of analysis (CoAs) provided by the supplier. Request batch-specific CoAs showing HPLC purity ≥98% for each peptide separately, mass spectrometry molecular weight confirmation (5,136 Da for tesamorelin, 711.85 Da for ipamorelin), and endotoxin testing below 5 EU/mg. The CoA must include the test date, batch number matching your vial, and an accredited third-party lab signature — in-house testing by the supplier isn’t independent verification. A CoA listing ‘total peptide content’ without separating tesamorelin and ipamorelin purity percentages is scientifically inadequate for blend verification. HPLC testing must resolve both peptides as distinct peaks with individual purity reports — combined percentages can’t confirm that both peptides are present at the stated ratio or that either peptide meets the ≥98% purity threshold. This is a major red flag signaling either incomplete testing or intentional obfuscation of low-purity components. Counterfeit peptides pose both efficacy and safety risks. Substituted amino acid sequences can create entirely different biological effects, including off-target receptor binding that triggers unintended physiological responses. Degraded peptides form aggregates that provoke immune reactions, and bacterial endotoxin contamination (common in unverified synthesis) causes systemic inflammation even at microgram exposure levels. The assumption that fake peptides are merely inactive underestimates the biochemical consequences of unverified compounds. Authentic reconstituted tesamorelin + ipamorelin should be completely clear and colorless within 60–90 seconds of adding bacteriostatic water, with no cloudiness, particulates, or sediment visible under normal light. The solution should remain stable — clear and colorless — when refrigerated at 2–8°C for up to 28 days. Any yellowing, browning, haziness, or visible particles developing within the first week indicates oxidation, degradation, or contamination, and the vial should be discarded immediately. HPLC measures purity — the percentage of the sample that is peptide versus non-peptide contaminants — but it cannot confirm which peptide you have. Two different peptides of similar molecular weight can show identical HPLC retention times and purity percentages despite having completely different amino acid sequences. Mass spectrometry confirms the exact molecular weight, which verifies the peptide’s amino acid composition and distinguishes authentic tesamorelin (5,136 Da) and ipamorelin (711.85 Da) from substituted analogs. Lyophilized tesamorelin + ipamorelin stored at −20°C in sealed, desiccated conditions typically remains stable for 24–36 months from the synthesis date. However, any temperature excursion above −10°C accelerates degradation, and exposure to humidity initiates hydrolysis even in powder form. The expiration date on the vial assumes continuous frozen storage